ArticleJournal of cancer research and clinical oncology2009

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment.

Oumar Camara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.